Is It Still Safe to Buy GlaxoSmithKline plc (ADR) (GSK)?

Foolish summary

So overall, based on the company’s predicted growth rate, higher than average dividend yield and share buyback program, I believe that GlaxoSmithKline still looks safe to buy at 1,630 pence.

More FTSE opportunities

As well as GlaxoSmithKline, I am also positive on the five FTSE shares highlighted within this exclusive wealth report.

Indeed, all five opportunities offer a mix of robust prospects, illustrious histories and dependable dividends, and have just been declared by the Fool as “5 Shares You Can Retire On”!

Just click here for the report — it’s free.

In the meantime, please stay tuned for my next FTSE 100 verdict.

The article Is It Still Safe to Buy GlaxoSmithKline? originally appeared on Fool.com and is written by Rupert Hargreaves.

Fool contributor Rupert Hargreaves has no position in any stocks mentioned. The Motley Fool recommends GlaxoSmithKline. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.